Olympus Corp ADR - Unsponsored OLYMY
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Shares Outstanding
- 1.06B
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 19.86
- Price/Sales
- 1.78
- Dividend Yield (Trailing)
- 1.69%
- Dividend Yield (Forward)
- 1.69%
- Dividend Payment Schedule
- Jun
- Total Yield
- 4.92%
Company Profile
Olympus is a medical-device maker with a leading position in the endoscope market and a diversified global revenue stream. Originally founded in 1919 in Japan as a microscope and camera maker, Olympus has gradually pivoted into endoscopic and therapeutic solutions. As of March 2025, more than 60% of its revenue comes from endoscopic solutions. In addition, North America is the biggest revenue contributor by region, accounting for 38% of its total revenue.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Large Core
- Total Number of Employees
- 27,634
- Website
- https://www.olympus.co.jp
Valuation
Metric | OLYMY |
|---|---|
Price/Earnings (Normalized) | 19.86 |
Price/Book Value | 2.45 |
Price/Sales | 1.78 |
Price/Cash Flow | 11.64 |
Price/Earnings
OLYMY
Financial Strength
Metric | OLYMY |
|---|---|
Quick Ratio | 1.03 |
Current Ratio | 1.67 |
Interest Coverage | 16.79 |
Quick Ratio
OLYMY
Profitability
Metric | OLYMY |
|---|---|
Return on Assets (Normalized) | 6.18% |
Return on Equity (Normalized) | 11.86% |
Return on Invested Capital (Normalized) | 9.12% |
Return on Assets
OLYMY
Medical Devices Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Abbott Laboratories ABT | LOCK|vGbMcr | LOCK|#>c<P | $188B | |||
| Medtronic PLC MDT | LOCK|%$!GPq | LOCK|%t!q! | $132B | |||
| Stryker Corp SYK | LOCK|<PX!^Qr | LOCK|dJG | $118B | |||
| Boston Scientific Corp BSX | LOCK|c>Bn?s^ | LOCK|&?<H | $64B | |||
| Edwards Lifesciences Corp EW | LOCK|$rwYGv?< | LOCK|sW<Y^ | $62B | |||
| GE HealthCare Technologies Inc Common Stock GEHC | LOCK|Y<Vh$Lb | LOCK|<? | $38B | |||
| DexCom Inc DXCM | LOCK|zkh@PzTW | LOCK|?S^C | $31B | |||
| Koninklijke Philips NV ADR PHG | LOCK|%<# | LOCK|@J | $30B | |||
| Steris PLC STE | LOCK|!<fZ&< | LOCK|D?lR | $26B | |||
| Zimmer Biomet Holdings Inc ZBH | LOCK|%n$>%yL^ | LOCK|Q$& | $20B |
United States